← Leaderboards
Ann E Stapleton
University Of Washington
$5,801,835
Attributed
$5,801,835
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2005–15$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$6,979,848 · 8
By mechanism
R01$4,622,286 · 3
P01$2,205,562 · 4
R03$152,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- James D. Bryers$16,072,511
- Ferric C Fang$28,333,027
- Anna Wald$34,443,936
- Robert Vessella$14,829,966
- Susan W Herring$6,502,804
Others in their field
Top investigators on “Escherichia Coli”
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Scott J Hultgren · Washington University$41,419,179
- John L Markley · University Of Wisconsin Madison$37,032,573
- Wilhelmus G. J. Hol · University Of Washington$31,124,692
- Vanessa Sperandio · University Of Wisconsin-Madison$27,468,669
- Peter D Karp · Sri International$27,278,650
Research focus
Escherichia ColiUrinary Tract InfectionLactobacillusVaginaGlycosphingolipidsCytokineUrinary Bladder EpitheliumBacteriuriaEpithelial CellsWomanMicroorganism CultureTissue /Cell CultureUropathogenPreventionAntimicrobialProbioticsPreventAntibioticsBacteria Infection MechanismUrineAntimicrobial ResistanceBaseInfectionDesign
Grant awards (22)
Lactobacillus probiotic for prevention of recurrent UTI$610,127
R01 · FY2015 · DK · contact PI
Lactobacillus probiotic for prevention of recurrent UTI$610,127
R01 · FY2014 · DK · contact PI
Lactobacillus probiotic for prevention of recurrent UTI$588,774
R01 · FY2013 · DK · contact PI
Lactobacillus probiotic for prevention of recurrent UTI$610,128
R01 · FY2012 · DK · contact PI
Lactobacillus probiotic for prevention of recurrent UTI$620,128
R01 · FY2011 · DK · contact PI
PATHOGENIC MECHANISMS IN URINARY TRACT INFECTION$1,178,013
P01 · FY2007 · DK · contact PI
Laboratory Core$218,281
P01 · FY2007 · DK · contact PI
Probiotic Lactobacilli and Vaginal Epithelium$215,616
R01 · FY2007 · DK · contact PI
ROLE OF BLADDER AND VAGINAL EPITHELIAL CAVEOLAE IN UTIs$169,528
R01 · FY2007 · DK · contact PI
Probiotic Lactobacilli and Vaginal Epithelium$221,111
R01 · FY2006 · DK · contact PI
ROLE OF BLADDER AND VAGINAL EPITHELIAL CAVEOLAE IN UTIs$174,592
R01 · FY2006 · DK · contact PI
Probiotic Lactobacilli and Vaginal Epithelium$227,400
R01 · FY2005 · DK
ROLE OF BLADDER AND VAGINAL EPITHELIAL CAVEOLAE IN UTIs$178,794
R01 · FY2005 · DK
ROLE OF BLADDER AND VAGINAL EPITHELIAL CAVEOLAE IN UTIs$178,794
R01 · FY2004 · DK
ROLE OF BLADDER AND VAGINAL EPITHELIAL CAVEOLAE IN UTIs$217,167
R01 · FY2003 · DK
CORE--LABORATORY$211,312
P01 · FY2002 · DK
BLADDER GLYCOSPHINGOLIPIDS IN THE PATHOGENESIS OF URINARY TRACT INFECTION$211,312
P01 · FY2002 · DK
CORE--LABORATORY$0
P01 · FY2001 · DK
BLADDER GLYCOSPHINGOLIPIDS IN THE PATHOGENESIS OF URINARY TRACT INFECTION$0
P01 · FY2001 · DK
CORE--LABORATORY$193,322
P01 · FY2000 · DK
BLADDER GLYCOSPHINGOLIPIDS IN THE PATHOGENESIS OF URINARY TRACT INFECTION$193,322
P01 · FY2000 · DK
IN VITRO MODEL OF HUMAN VAGINAL EPITHELIUM$152,000
R03 · FY2000 · HD